Opioids is one of 75 small molecule programs targeting Emergence Delirium. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
77 competitors in Chronic Pain
Marinol
Intuniv
Precedex
Pitocin
Norpramin
Decadron
Ultram
Dilaudid
Advil
Epsom Salt
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details